224 related articles for article (PubMed ID: 29742598)
1. Unicentric Castleman's Disease Revealed by 18F-FDG PET/CT and Somatostatin Receptor Scintigraphy With 99mTc-HYNIC-TOC.
Luo Y; Wang L; Pan Q; Ma Y; Li F
Clin Nucl Med; 2018 Jul; 43(7):551-552. PubMed ID: 29742598
[TBL] [Abstract][Full Text] [Related]
2. A Mixed Variant of Castleman Disease Detected by Somatostatin Receptor Scintigraphy with 99mTc-HYNIC-TOC and 18F-FDG PET/CT.
Pan Q; Zhang X; Luo Y; Ma Y; Li F
Clin Nucl Med; 2019 Feb; 44(2):164-166. PubMed ID: 30516666
[TBL] [Abstract][Full Text] [Related]
3. Adrenal Castleman Disease on 99mTc-HYNIC-TOC Scan and FDG PET/CT.
Ding J; Cheng X; Hou G; Jing H; Huo L
Clin Nucl Med; 2021 Jan; 46(1):71-73. PubMed ID: 32956111
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 99mTc-HYNIC-TOC and HYNIC-TATE octreotide scintigraphy with FDG PET and 99mTc-MIBI in local recurrent or distant metastatic thyroid cancers.
Sager S; Kabasakal L; Halac M; Maecke H; Uslu L; Önsel Ç; Kanmaz B
Clin Nucl Med; 2013 May; 38(5):321-5. PubMed ID: 23531772
[TBL] [Abstract][Full Text] [Related]
5. Castleman's Disease of the Kidney Mimicking Renal Cell Carcinoma on FDG PET/CT.
Wang Y; Dong A; Yang B; Lu J
Clin Nucl Med; 2018 May; 43(5):e160-e163. PubMed ID: 29432340
[TBL] [Abstract][Full Text] [Related]
6. Hypermetabolic Unicentric Castleman Disease of Kidney on FDG PET/CT.
Wang P; Hou G; Li F; Cheng X
Clin Nucl Med; 2021 Jun; 46(6):510-511. PubMed ID: 33939651
[TBL] [Abstract][Full Text] [Related]
7. Influence of PET/CT 68Ga somatostatin receptor imaging on proceeding with patients, who were previously diagnosed with 99mTc-EDDA/HYNIC-TOC SPECT.
Madrzak D; Mikołajczak R; Kamiński G
Nucl Med Rev Cent East Eur; 2016; 19(2):88-92. PubMed ID: 27479886
[TBL] [Abstract][Full Text] [Related]
8. Abdominal Castleman's disease with 18F-FDG PET/CT.
Badenes Romero Á; Milà López M; Vallansot RO; Achury Murcia CA; Patricia Fierro Alanis M; Carrera Salazar D; Muro VI; Quintero Caicedo LM
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(6):418-419. PubMed ID: 37422261
[No Abstract] [Full Text] [Related]
9. A rare case of Castleman disease mimicking a pancreatic tumor.
Gülmez S; Keklikkıran ZZ; Ölmez T; Barışık NÖ
Ann Ital Chir; 2019 Dec; 8():. PubMed ID: 31894755
[TBL] [Abstract][Full Text] [Related]
10. Follicular dendritic sarcoma within a focus of Castleman's disease. Serial FDG PET/CT in the follow up of recurrence with histopathologic confirmation.
Iagaru A; Mari C; Sam Gambhir S
Rev Esp Med Nucl; 2007; 26(1):40-5. PubMed ID: 17286947
[TBL] [Abstract][Full Text] [Related]
11. Castleman's disease. Large retroperitoneal masses and multiple calcifications detected by
Xiao L; Zhu HM; Li L
Hell J Nucl Med; 2019; 22(3):220-221. PubMed ID: 31587031
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic Pemphigus Associated With Castleman Disease Detected by 18F-FDG PET/CT.
Fu Z; Liu M; Chen X; Yang X; Li Q
Clin Nucl Med; 2018 Jun; 43(6):464-465. PubMed ID: 29561527
[TBL] [Abstract][Full Text] [Related]
13. A huge retroperitoneal Castleman's disease - rare entity.
Jaishanker S; D'Cruze L; Muralidharan S; Gunabooshanam B; Singh KB
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S980-S982. PubMed ID: 38384096
[TBL] [Abstract][Full Text] [Related]
14. A 10-year observational single-center study of retroperitoneal unicentric Castleman disease.
Wang W; Dong D; Wen J; Li H
Medicine (Baltimore); 2021 Mar; 100(10):e25088. PubMed ID: 33725899
[TBL] [Abstract][Full Text] [Related]
15. PET/CT imaging with 18F-FDG in Castleman disease.
Delgado A; Mesa J; Guayambuco S; Rodriguez T; Fernández I; Rodeño E
Rev Esp Med Nucl Imagen Mol; 2016; 35(3):200-1. PubMed ID: 26614744
[No Abstract] [Full Text] [Related]
16. FDG positron emission tomographic scintigraphy can reveal Castleman's disease as a cause of inflammation.
Blockmans D; Maes A; Stroobants S; Bobbaers H; Mortelmans L
Clin Nucl Med; 2001 Nov; 26(11):975-6. PubMed ID: 11595872
[No Abstract] [Full Text] [Related]
17.
He L; Chen Y; Tan X; Sun X; Zhang Q; Luo H; Jiang L
Jpn J Radiol; 2023 Jan; 41(1):98-107. PubMed ID: 35895223
[TBL] [Abstract][Full Text] [Related]
18.
Fernández-Rodríguez P; Fernández López R; Acevedo Báñez I; Mohigefer Barrera J; Jiménez-Hoyuela García JM
Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):222-223. PubMed ID: 31494704
[TBL] [Abstract][Full Text] [Related]
19. 99mTc-HYNIC-TOC scintigraphy is superior to 131I-MIBG imaging in the evaluation of extraadrenal pheochromocytoma.
Chen L; Li F; Zhuang H; Jing H; Du Y; Zeng Z
J Nucl Med; 2009 Mar; 50(3):397-400. PubMed ID: 19223405
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin receptor scintigraphy using 99mTc-EDDA/HYNIC-TOC in patients with medullary thyroid carcinoma.
Czepczyński R; Parisella MG; Kosowicz J; Mikołajczak R; Ziemnicka K; Gryczyńska M; Sowiński J; Signore A
Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1635-45. PubMed ID: 17530247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
